Boston Scientific CorporationBSX

Where BSX's EV/EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$42.69+0.26 (+0.61%)Previous close
NYSEHealthcare

BSX EV/EBITDA: current value, 10-year range and year-by-year history

EV/EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
BSX EV/EBITDA historyBSX EV/EBITDA from Oct 2023 to Sep 2026: low 12.99, high 43.05, latest 13.31.10.5919.328.0236.7445.45Oct 23May 24Dec 24Aug 25Mar 26Sep 26med 32.13

BSX EV/EBITDA by year

Yearly range of BSX’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 13.0 to 106.8, averaging 31.4.

BSX EV/EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
202613.018.732.213.3
202529.536.543.031.2
202427.133.538.736.6
202324.128.130.928.2
202222.426.730.530.0
202123.436.847.727.2
202021.138.656.043.8
201920.625.633.533.5
201819.923.026.321.9
201721.531.441.721.5
201697.9102.9106.8104.3

Get notified when BSX EV/EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.

Formula(Market Cap + Net Debt) / EBITDA
Full guide
How to read this chart

Unlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.

Key caveats
  • EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
  • Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.